Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells
about
Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migrationPhosphorylation of the human-transforming-growth-factor-beta-binding protein endoglinIncreased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patientsHereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of diseaseBetaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sitesLatent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding proteinThe activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanomaA "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healingHighlights on endoglin (CD105): from basic findings towards clinical applications in human cancerAnti-angiogenic alternatives to VEGF blockadeOveractive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophyContrasting roles of different endoglin forms in atherosclerosisTGF-β - an excellent servant but a bad masterCaenorhabditis elegans SMA-10/LRIG is a conserved transmembrane protein that enhances bone morphogenetic protein signalingThe Discovery and Early Days of TGF-β: A Historical PerspectiveModern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targetsEndoglin is required for myogenic differentiation potential of neural crest stem cellsGrowth factor priming differentially modulates components of the extracellular matrix proteome in chondrocytes and synovium-derived stem cellsComparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer CellsQuantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell functionA murine model of hereditary hemorrhagic telangiectasiaCellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetesMechanistic exploration of phthalimide neovascular factor 1 using network analysis tools.Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group studyEndoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.An M1-like Macrophage Polarization in Decidual Tissue during Spontaneous Preterm Labor That Is Attenuated by Rosiglitazone Treatment.ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expressionEndoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.Molecular mechanisms of preeclampsia.Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior.A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteriesHereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanismsMedical applications of transforming growth factor-betaEndoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading.Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceAngiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsiaEffects of serial passage on the characteristics and chondrogenic differentiation of canine umbilical cord matrix derived mesenchymal stem cells
P2860
056620dbd5f1f91f1d45beef806b1d94c58827193781920ac2f8b4db5345519646ac23b05b165989381ea7c962fc5234b1be1ff2e164171847fbc21a5b7cb1a9eca463fe6e5b0397fb454b1a5bc86ec260cdc3549a0e136a6a445e7b61e52393c762c3af70f5947f9972dd02fb6954e8262133eb1356812783e1840c3039206abca3138633e230f554816640849e9bc2ecdf9463f96143a32ef2df0d9940549cd0293e3b750184771c9a27dec16a242b01538600d947e688cdbf2aa4c81fcac1ddef7082ab07bcf8
P248
Q24304467-DE421D09-B2AB-4311-B0C4-235CF59EDA20Q24314139-ADA51373-D864-41E4-A7E3-226958111EA0Q24316465-C0B7B5DC-A246-4DF8-B851-256FD283259DQ24619354-39C6C873-DBA4-4E25-9D3C-F8E857C4A6F6Q24645017-F68A0DEB-9B71-413D-BFFE-4F0C6DA10C2BQ24673586-1B5BC844-65F6-439B-A03D-7F6742A22779Q24673676-7874D66C-55F4-4D81-9BC8-48357DCB1F72Q24678806-E6CBD90D-FF4E-491F-B186-3D655254C2F2Q24679708-C3964F16-784F-48AB-9EF3-5C96EE50A918Q24683724-3259E42D-C52C-4DAD-828F-EDF1FD72BB25Q24798737-6496CEAB-D969-43E1-B904-5D9F11C0DB69Q26775947-4B49B32D-BF63-4F53-A1F6-298B7C7F56A2Q26864900-84149316-C6AB-46C1-AEFD-4B7900E0210BQ26995380-B8F21DE7-7040-4E60-A7AA-28797BEC5767Q27025590-9E383416-54D8-4C52-BBDA-5B113EDE02C0Q27347461-BCA82083-C730-41EC-9704-6F05EF1C9C3CQ28276556-D60816BC-528D-491C-8DF5-A698F71851E3Q28303698-868FB56B-11CF-4279-B80D-79A9A49C701CQ28510584-5DFAD44C-2143-46EC-9751-4ADD2BDD1FB3Q28539657-EEF4F573-B728-41E5-8A51-BFAE04C90575Q28553202-C4A2CC1B-FBB6-46AA-88D1-AD863335D876Q28591865-4666F29C-71A2-448F-BE5D-2597CD006E7AQ28592376-B4D98B21-3E9E-4BC9-8E6F-6ED508E98A1EQ30419393-D93D90DF-1995-4897-9A57-9588334063DAQ30431758-2805D49B-A7A3-487E-BF11-DD293CEDBFDBQ30436395-39E47B87-B556-43CF-96E9-A39A6377B197Q30480194-2FF10887-EF91-4845-9088-F3A13A94160FQ30724406-FE277C99-7C4E-485F-9EEE-A71A8A085873Q30811602-0101B787-8670-448F-8463-899EB1CA62F2Q31126839-1EB744FB-11D7-4BF7-A108-A2D6EDEDFC89Q33344105-BAC2FF6F-A401-4E6C-827C-234B3EBB129DQ33349894-2930E1D2-D082-45B7-93C9-E3685A940A6EQ33514953-0289AF88-9B85-4D50-80B6-AF9444E0F7A7Q33634727-47238020-5526-4438-AA34-EE5254801A6FQ33691285-EC656296-D0D9-4B7F-8423-18C1FEC54492Q33723271-20F0EDDF-6410-4C9B-AED1-7AB57E2AA79AQ33727308-26539B01-9748-4F74-A4B9-AE376A71C757Q33728841-04396B0C-C916-419E-B6B3-CF462E21AA70Q33748650-9E6FAA5A-1A9F-459C-8183-77A2EC9925E7Q33885788-F5BCEA09-6359-4ADB-9523-8AFE0AFDC92B
P2860
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Endoglin is a component of the ...... tem in human endothelial cells
@ast
Endoglin is a component of the ...... tem in human endothelial cells
@en
Endoglin is a component of the ...... tem in human endothelial cells
@en-gb
Endoglin is a component of the ...... tem in human endothelial cells
@nl
type
label
Endoglin is a component of the ...... tem in human endothelial cells
@ast
Endoglin is a component of the ...... tem in human endothelial cells
@en
Endoglin is a component of the ...... tem in human endothelial cells
@en-gb
Endoglin is a component of the ...... tem in human endothelial cells
@nl
prefLabel
Endoglin is a component of the ...... tem in human endothelial cells
@ast
Endoglin is a component of the ...... tem in human endothelial cells
@en
Endoglin is a component of the ...... tem in human endothelial cells
@en-gb
Endoglin is a component of the ...... tem in human endothelial cells
@nl
P2093
P921
P3181
P1476
Endoglin is a component of the ...... tem in human endothelial cells
@en
P2093
C Bernabeu
J Massagué
S Cheifetz
P304
P3181
P407
P577
1992-09-25T00:00:00Z